Clonazepam: Difference between revisions

Jump to navigation Jump to search
m (Protected "Clonazepam": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
m (Changed protection level for "Clonazepam" ([Edit=Allow only autoconfirmed users] (expires 19:14, 26 February 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 19:14, 26 February 2014 (UTC))))
(No difference)

Revision as of 19:14, 12 February 2014

Synonyms / Brand Names: Antelepsin, Antilepsin , Cloazepam, Clonopin, Iktorivil , Klonopin, Klonopin rapidly disintegrating, Landsen, Rivotril

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosing and Administration

Seizure disorder: For adults, the initial dose for adults with seizure disorders should not exceed 1.5 mg/day divided into three doses. Maintenance dosage must be individualized for each patient depending upon response. Maximum recommended daily dose is 20 mg. For pediatric patients: the initial dose for infants and children (up to 10 years of age or 30 kg of body weight) should be between 0.01 and 0.03 mg/kg/day but not to exceed 0.05 mg/kg/day given in two or three divided doses. Dosage should be increased by no more than 0.25 to 0.5 mg every third day until a daily maintenance dose of 0.1 to 0.2 mg/kg of body weight has been reached, unless seizures are controlled or side effects preclude further increase.
Panic disorder:For adults, he initial dose for adults with panic disorder is 0.25 mg bid. An increase to the target dose for most patients of 1 mg/day may be made after 3 days. The maximum dose is 4 mg/day. For pediatric patients, there is no clinical trial experience.



FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Clonazepam

Return to top

Publication Resources

Most Recent Articles on Clonazepam

Review Articles on Clonazepam

Articles on Clonazepam in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Clonazepam

Return to top

Trial Resources

Ongoing Trials with Clonazepam at Clinical Trials.gov

Trial Results with Clonazepam

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Clonazepam

Cochrane Collaboration on Clonazepam

Cost Effectiveness of Clonazepam

Return to top

Media Resources

Powerpoint Slides on Clonazepam

Images of Clonazepam

Podcasts & MP3s on Clonazepam

Videos on Clonazepam

Return to top

Patient Resources

Patient Information from National Library of Medicine

Patient Resources on Clonazepam

Discussion Groups on Clonazepam

Patient Handouts on Clonazepam

Blogs on Clonazepam

Clonazepam in the News

Clonazepam in the Marketplace

Return to top

International Resources

Clonazepam en Español

Return to top


Adapted from the FDA Package Insert.